Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock

Letson, Hayley Louise, Morris, Jodie Louise, Biros, Erik, and Dobson, Geoffrey Phillip (2019) Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock. Journal of Trauma and Acute Care Surgery, 87 (3). pp. 606-613.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: https://doi.org/10.1097/TA.0000000000002...
 
3
3


Abstract

BACKGROUND: Non-compressible torso hemorrhage is a leading cause of traumatic death. Our aim was to examine survival time and the expression of key master genes of cellular metabolism after 3% NaCl adenosine, lidocaine and Mg (ALM) bolus and 4hr 0.9% NaCl/ALM 'drip' in a rat model of uncontrolled hemorrhagic shock.

METHODS: Male Sprague-Dawley rats (425±8g) were anesthetized and randomly assigned to saline controls (n=10) or ALM therapy (n=10). Hemorrhage was induced by liver resection (60% left lateral lobe). After 15min, a single intravenous bolus of 3% NaCl ± ALM (0.7ml/kg) was administered (Phase 1), and after 60min, a 0.9% NaCl ± ALM stabilization 'drip' (0.5ml/kg/hour) was infused for 4hrs (Phase 2) with 72hr monitoring. Mean arterial pressure and lactate were measured. After 72hrs (or high moribund score), tissues were freeze-clamped and stored at -80°C. Total RNA was extracted in heart, brain and liver, and the relative expressions of amp-k, mitCO3, PGC-1α and sirt-1 genes were determined.

RESULTS: Kaplan-Meier survival curves showed that controls had a mean survival time of 22.6±4.5hr and ALM animals 72±0hr (p<0.05). Death in controls was accompanied by ~7-fold increase in lactate, while ALM animals maintained lactates similar to baseline over 72hrs. The relative expression of amp-k, PGC-1α, and sirt-1 in heart and brain was 1.5- and 2.7-fold higher in the ALM group compared to controls (p<0.05), with the exception of mtCO3 in heart, which was 19-fold higher. In contrast, amp-k, sirt-1 and mitCO3 gene expression in liver was significantly 29-41% lower in the ALM group compared to controls, and PGC-1α was 75% lower.

CONCLUSIONS: Small-volume ALM therapy led to 3.3-times longer survival time compared to saline controls after hemorrhagic shock. A hallmark of the ALM-survival phenotype in heart and brain was an upregulation of amp-k, PGC-1α, sirt-1 and mitCO3 to presumably 'boost' mitochondrial function and ATP production, and a contrasting downregulation in liver. These central-peripheral differences in gene expression require further investigation.

LEVEL OF EVIDENCE: Randomized animal study.

Item ID: 58715
Item Type: Article (Research - C1)
ISSN: 2163-0763
Keywords: Noncompressible hemorrhage; ALM; survival; genetics; metabolism; far forward; hypotensive resuscitation
Copyright Information: © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Funders: US Department of Defense (DOD), James Cook University (JCU)
Date Deposited: 09 Jul 2019 04:06
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1199 Other Medical and Health Sciences > 119999 Medical and Health Sciences not elsewhere classified @ 80%
11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110299 Cardiovascular Medicine and Haematology not elsewhere classified @ 20%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 20%
92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920199 Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified @ 80%
Downloads: Total: 3
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page